In multicellular organisms, the timing and placement of gene expression in a developing tissue assigns the 15 fate of each cell in the embryo in order for a uniform field of cells to differentiate into a reproducible 16 pattern of organs and tissues. This positional information is often achieved through the action of spatial 17 gradients of morphogens. Spatial patterns of gene expression are paradoxically robust to variations in 18 morphogen dosage, given that, by definition, gene expression must be sensitive to morphogen 19 concentration. In this work we investigate the robustness of the Dorsal/NF-κB signaling module with 20 respect to perturbations to the dosage of maternally-expressed dorsal mRNA. The Dorsal morphogen 21 gradient patterns the dorsal-ventral axis of the early Drosophila embryo, and we found that an empirical 22
description of the Dorsal gradient is highly sensitive to maternal dorsal dosage. In contrast, we found 23 experimentally that gene expression patterns are highly robust. Although the components of this signaling 24 module have been characterized in detail, how their function is integrated to produce robust gene 25 expression patterns to variations in the dorsal maternal dosage is still unclear. Therefore, we analyzed a 26 mechanistic model of the Dorsal signaling module and found that Cactus, a cytoplasmic inhibitor for 27 Dorsal, must be present in the nucleus for the system to be robust. Furthermore, active Toll, the receptor 28 that dissociates Cactus from Dorsal, must be saturated. Finally, the vast majority of robust descriptions of 29 the system require facilitated diffusion of Dorsal by Cactus. Each of these three recently-discovered 30 mechanisms of the Dorsal module are critical for robustness. Our work highlights the need for quantitative 31 understanding of biophysical mechanisms of morphogen gradients in order to understand emergent 32 phenotypes, such as robustness. 33 34 Introduction 50
The morphogen concept forms the basis of many models of developing tissues. Through their 51 concentration gradients in space, morphogens send positional information to cells and direct them to 52 develop in specific ways depending on their location within a tissue. The roles of these signals range from 53 the development of the initial polarities of embryos to specification of cell identity in specific tissues, and 54 the nervous system in both vertebrates and Drosophila [1] . Tissue patterning is often initiated by the cells' 55 concentration-dependent response to the morphogen gradient: cells throughout the tissue are subject to 56 different levels of morphogen, depending on their position within the field, and accordingly, express 57 4 distinct target genes. Thus, the quantitative shape of the morphogen gradient is critical for patterning, 58 with cell-fate boundaries established at specific concentration thresholds. The cells' sensitivity to 59 morphogen concentration also implies that any shift in the morphogen distribution is expected to result 60 in an accompanying shift in patterning. Therefore, perturbations to the morphogen dosage or production 61 rate, which should change the morphogen distribution, should in turn perturb gene expression patterns. 62
Indeed, early models of morphogen gradient formation assumed the gradient scaled globally with the 63 morphogen dose (e.g., when one copy of the gene encoding the morphogen is lost, the entire distribution 64 is divided by two). Such "dosage-scaling" models predicted that catastrophic shifts in target gene 65 expression domains would occur when the dose of morphogen is altered [2, 3] . In contrast, experimental 66 observations have shown that the spatial positioning of morphogen target genes shift only minimally 67 when morphogen dosage is perturbed [2] [3] [4] [5] , with some notable exceptions [6, 7] . Thus, there exists a 68 paradox between the sensitivity of cells to morphogen concentration and the robustness of tissue 69 patterns with respect to morphogen dose, which implies a mechanism that prevents robust morphogen 70 gradient systems from scaling with morphogen dose. One such mechanism is self-enhanced ligand 71 degradation, where the ligand (morphogen) upregulates its own inhibitor, and which has been suggested 72 to explain experimentally-observed robustness [3, 4, 8, 9] . However, this mechanism does not apply to all 73 morphogen gradient systems. In particular, the Dorsal/NF-κB signaling network in Drosophila embryos 74 does not clearly exhibit the self-enhanced degradation mechanism. 75
The NF-B module, conserved from flies to humans, is implicated in several cellular 76 responses/phenotypes, including tissue patterning, inflammation, innate immunity, 77 proliferation/apoptosis, and cancer [10] [11] [12] [13] [14] . The maternal transcription factor Dorsal (Dl), homologous to 78 mammalian NF-κB, patterns the dorsal-ventral (DV) axis of the developing Drosophila melanogaster 79 embryo to specify mesoderm, neurogenic ectoderm, and dorsal ectoderm cell fates (Roth et al., 1989; 80 reviewed in [16-18] . In the early embryo, Dl protein is initially uniformly distributed around the DV axis. 81 5 During nuclear cleavage cycle (nc) 10, the nuclei migrate to the periphery of the syncytial blastoderm and 82 the Dl gradient begins to be established. The IκB homolog Cactus (Cact), which is also maternally-supplied, 83 binds to Dorsal, retaining it outside the nuclei. Toll, the Drosophila homolog of the Interleukin 1 receptor, 84 is active on the ventral side of the embryo, where it signals through Pelle kinase to phosphorylate the 85 Dl/Cact complex [19] , which results in dissociation of Dl from Cact, allowing Dl to enter the nuclei, where 86 it regulates gene expression. Because Toll signaling is spatially asymmetric, a nuclear gradient of Dl forms, 87 with a peak at the ventral midline and a Gaussian-like decay in space to become nearly flat at 88 approximately 45% of the embryo's circumference ( Figure 1A ) [5, 20] . From 45% to 100% ventral-to-dorsal 89 coordinate, the gradient has a shallow downward slope to achieve non-zero basal levels at the dorsal 90 midline [5, 20, 21] . Our computational studies have suggested the non-zero basal levels are primarily 91 composed of Dl/Cact complex in the dorsal-most nuclei, not free Dl [22] . 92
As shown in Figure 1B , different genes are turned on at different concentrations of Dl [16, 23] . It can be 93 both an activator and a repressor of transcription. At high concentrations of Dl on the ventral side of the 94 embryo, high threshold genes such as snail (sna) are expressed. In the lateral part of the embryo, 95
intermediate Dl levels activate the expression of low threshold genes such as short gastrulation (sog). The 96 domains of these genes can be quantified using measurements of the dorsal border and ventral border 97 ( Fig 1C) . 98
While the copy number of maternal dl has been shown to affect the Dl gradient and downstream tissue 99 structure, the phenotypes are subtle. Embryos from mothers heterozygous for a dl null allele (1x dl) have 100 shorter, wider, and flatter Dl gradients as compared to wildtype [5, [24] [25] [26] . While these embryos have a 101 weakly dorsalized phenotype, female flies with a half dose of dl produce a high fraction of viable progeny 102 at room temperature [27, 28] . Furthermore, measurements in a handful of embryos (n < 12) found no 103 statistical shift in the sog expression domain [5] , and a shift of roughly only one cell diameter in the sna 104 domain [26] . The altered shape of the Dl gradient has recently been attributed to a combination of two 105 6 novel observations. First, Cact acts to facilitate the diffusion of Dl (i.e., "shuttling" of Dl by Cact), which 106 results in a net flux of Dl to the ventral side of the embryo [26] . And second, active Toll receptor complexes 107 are saturated by Dl/Cact complex [26] . Together, these processes act to accumulate Dl on the ventral side 108 in wildtype embryos, but accumulate Dl in ventral-lateral regions in 1x dl embryos. Furthermore, 109 experimental evidence strongly suggests the shuttling mechanism is required for viability of 1x dl embryos, 110 as embryos from heterozygous dl mothers that also have compromised shuttling are non-viable [26] . 111
In a similar manner, embryos with overexpression of excess, transgenic copies of dl (4x dl) are only weakly 112 ventralized, and a large fraction still hatch [29] . Given the subtlety of the 1x and 4x dl phenotypes, and 113 the viability of the embryos, one may ask whether this implies the Dl gradient system is robust, and if so, 114
whether the robustness requires special mechanisms, such as shuttling and Toll saturation [26] . As 115 mentioned above, dosage-scaling models are typically sensitive to dosage; however, such a model of the 116 Dl gradient has not been analyzed for robustness of gene expression with respect to variations in 117 morphogen dosage. 118
In this work, we used empirical and computational modeling, together with quantitative measurements 119 of the Dl gradient and domains of target gene expression, to investigate the robustness of the Dl gradient 120 system with respect to dosage of maternal dl. First, we showed that a dosage-scaling formulation of the 121 Dl gradient has an unacceptably high sensitivity to the maternal dosage of dl, even in the best-case 122 scenario, in which basal levels are composed primarily of Dl/Cact complex and there is negligible Dl activity 123 at the dorsal midline [22] . In particular, in the absence of a mechanism to prevent dosage-scaling, doubling 124 or halving the maternal dl dosage is predicted to result in drastic perturbations to gene expression. Next, 125 we experimentally measured gene expression domains and the Dl gradient width in embryos from 126 mothers with dl dosages of 1x (heterozygous null for maternal dl), 2x (wildtype), and 4x (expressing two 127 copies of a dl rescue construct; Carrell et al., 2017; Reeves et al., 2012) and showed that, in contrast to 128 the predictions of the dosage-scaling model, the perturbations to patterns are minimal. To identify the 129 7 possible mechanism for this robustness, we analyzed a computational model of the Dl/Cact system. Our 130 model is based on previously published models in which Dl and Cact can interact, enter the nuclei, and 131 diffuse between "cytoplasmic compartments" surrounding the nuclei [21, 22, 24, 26, 30] . The active Toll 132 signaling complex, which is limited to the ventral side of the embryo, acts as a Michaelis-Menten-like 133 enzyme to favor dissociation of the Dl/Cact complex. We constrained the model using our measurements 134 of Dl target gene expression in 1x, 2x, and 4x embryos. A random parameter search showed that several 135 parameter sets resulted in robust phenotypes. Our analysis of the robust parameter sets showed that 136 robustness can rarely be achieved unless (1) 
Sensitivity of a dosage-scaling model of the Dl gradient 143
Early models of morphogen gradients exhibited "dosage-scaling," in that these descriptions of the 144 morphogen gradient scaled globally, in a multiplicative manner, with morphogen dosage. Morphogen 145 gradients predicted by these models were highly sensitive with respect to morphogen dosage [3, 31, 32] . 146
However, these models focused on exponential-like morphogen distributions, whereas the Dl gradient is 147 20, 26] . Therefore, to determine the extent to which the robustness of the Dl system 148 may be inherent to the Gaussian shape of the Dl gradient, versus how much of the robustness requires a 149 special mechanism, we analyzed an empirical, dosage-scaling description of the gradient. 150
Let ( ) be the distribution of nuclear Dl as a function of the DV coordinate : 151
where is a proportionality constant related to morphogen dosage, represents the spatial width of the 153 Dl gradient, is the shallow, downward slope of the Dl gradient tail, and represents the basal levels of 154 the gradient, related to the levels of Dl that is present in the dorsal-most nuclei. From empirical 155 measurements, ≈ 0.4 and ≈ −0.1 [20] . 156
To calculate the robustness of the predicted gene expression boundaries with respect to changes in , we 157 performed a sensitivity analysis. Let the sensitivity coefficient of a gene expression border with respect to 158 maternal dl dosage be defined as ≡ ( ln ln ⁄ ) , where is the location of gene expression 159 boundary and is the threshold in Dl nuclear concentration required to express the gene (see Materials  160 and Methods for more information). We found the model of the Dl gradient described by Eqn (1) has 161 unacceptably high values of the sensitivity coefficient ( Fig. 2A) . As a rule of thumb, sensitivity coefficients 162 should be designed to be 0.3 or less [32,33]; the gradient described by Eqn (1) has sensitivity coefficients 163 of one or greater. 164
Previously, it was found that a model in which both Dl and Dl/Cact complex are present in the nucleus was 165 more consistent with experimental results than one in which only free Dl is allowed to enter the nucleus 166
[22]. This model was also more robust to noise in Dl levels. Therefore, we asked whether empirically 167 modeling the presence of Dl/Cact complex in the nuclei could also improve the predicted robustness with 168 respect to maternal dl dosage. In this case, Eqn (1) represents the sum of the two Dl-containing species. 169
Deconvolution of the non-functional Dl/Cact contribution from the sum would result in the active, "true" 170 Dl gradient (i.e., free Dl). Our previous work has suggested the Dl/Cact contribution is roughly constant 171 across the DV axis [22] , so that empirically, the active Dl gradient can be modeled by Eqn (1) with a much 172 lower value of . If we set = 0.11, so that the intensity of free nuclear Dl in the dorsal-most nuclei is 1% 173 of the intensity in the ventral-most nuclei, the sensitivity of gene expression is improved markedly ( Fig. 9 2A). However, even in this best-case scenario, the minimum sensitivity coefficient (located at = 0.34) 175 remains unacceptably high, roughly 0.4, while gene expression boundaries located elsewhere experience 176 even higher sensitivities. 177
To put the problem in more experimentally concrete terms, we can use Eqn (1) to predict the outcome of 178 deleting one copy of maternal dl (1x dl), or expressing two extra copies (4x dl). Let = 1 to represent the 179 wildtype dosage of maternal dl, so that = 0.5 and = 2 represent the 1x and 4x embryos, respectively. 180
In the perturbed cases, the predicted DV gene expression profile in the embryo would result in lethality: 181 1x embryos completely lose sna expression, while 4x embryos have a highly expanded domain of sna and 182 lose dpp completely ( Fig. 2B ). As with the sensitivity coefficient above, if is lowered, the effects on gene 183 expression are less severe (Fig. 2C ). However, the empirical model still predicts lethality: 1x embryos 184 express sna in < 10% of the DV axis [26] , and 4x embryos have severely reduced dpp expression. We 185 conclude that robustness does not arise simply from a Gaussian shape in a dosage-scaling context, and 186 thus, there must be a mechanism by which the embryo compensates for changes in the maternal dl 187 dosage. 188 189
Robustness of Dl-dependent gene expression 190
While the dosage-scaling model predicted high sensitivity of gene expression, limited measurements of 191 gene expression in 1x and 4x embryos [5, 26] , as well as their viability [27] [28] [29] , suggest the system is robust. 192
To more accurately quantify the robustness of Dl target gene expression with respect to dl dosage, we 193 performed large sample size measurements (generally n ∼ 40 or greater) of the expression of two Dl 194 target genes, sna and sog, in 1x, 2x, and 4x embryos. We found that, with only one exception, the 195 expression domains of both genes in 1x and 4x embryos were statistically different from their expression 196 in 2x (wildtype) embryos (p-val ≤ 2× 10 -4 ; Fig 3) . The lone exception, the sna border in 4x embryos, had a 197 much smaller sample size than the rest (n = 13). Furthermore, the direction of the shifts in gene expression 198 boundaries were as one might expect: in 1x embryos, the gene expression domains shifted closer to the 199 ventral midline, while in 4x embryos, they shifted more dorsally. 200
Even though we were able to measure statistically significant differences from wildtype, the shifts in gene 201 expression borders were minimal (roughly 10% or less; see Table 1 ), in contrast to the predictions of the 202 dosage-scaling model (Eqn 1). Therefore, our quantification of the robustness of gene expression domains 203 further suggests that a mechanism exists to mitigate the effects of altering the dosage of maternal dl. We 204 suspected that this mechanism could be traced to the shape and width of the Dl gradient in 1x, 2x, and 4x 205 embryos. 206 207
Robustness of the Dl gradient 208
Previously, it has been shown that a half maternal dose of dl significantly shortens and widens the Dl 209 gradient, and results in a flattened, and sometimes double-peaked, top [5, [24] [25] [26] . Given that this outcome 210 cannot be predicted by the non-robust dosage-scaling description, in which the width and shape of the 211 gradient do not change with dosage, we asked whether such changes to the Dl gradient would be 212 sufficient to confer robustness to predicted gene expression. Therefore, we measured the Dl gradient in 213 embryos loaded with 1x, 2x, and 4x copies of maternal dl (see Fig. 4A and Table 1 ). As previously reported, 214 1x embryos had a wider and flatter Dl gradient [5, 26] . However, the previously-reported width 215 measurements for 1x embryos cannot be directly compared to widths in wildtype embryos, given the 216 width measurements are based on the assumption that the Dl gradient is Gaussian-shaped, which the 1x 217 Dl gradient is not. Accounting for the differing shape (see Supplementary information), the 1x Dl gradient 218 measures as narrower than wildtype (Fig. 4B) . 219 11 When we examined 4x embryos , we found the gradient became statistically wider (Table 1; Figs. 4 A,B) , 220 which also defies a dosage-scaling description of the Dl gradient. However, rather than explaining the 221 robustness of the Dl system, these measurements naïvely predict even higher sensitivities than the 222 dosage-scaling model. Consider the basic expectation that the 1x gradient should have a roughly 50% 223 lower amplitude than wildtype, while the 4x gradient should have a roughly 200% higher amplitude, even 224 if the gradients are not the exact shape and width as wildtype. The combination of decrease in gradient 225 amplitude and decrease in gradient width in 1x embryos, or an increase of both in 4x embryos, would 226 likely result in sensitive Dl-dependent gene expression, as the two effects (amplitude and width) 227 exacerbate each other. In contrast, the dosage-scaling model has only one effect: a changing gradient 228 amplitude. 229
One way to explain the robustness of gene expression, given the observed changes in Dl gradient shape 230 and width, would be if the amplitudes of the 1x and 4x gradients significantly departed from expectation. 231 Therefore, we computed the amplitudes for the 1x and 4x gradients, with respect to the 2x gradient 232 (which was set to an amplitude of one), that would most closely predict the experimentally observed gene 233 expression in these embryos ( Fig. 4C ; see Supplementary Methods). We found that a 1x gradient with > 234 50% of the wildtype amplitude, and a 4x gradient with < 100% of the wildtype amplitude, would be 235 consistent with the experimentally observed robust gene expression. While it is unlikely the 4x gradient 236 would have a shorter amplitude than the 2x gradient, values slightly greater than one are also acceptable 237 ( Fig. 4D) . 238
These results suggest that the mechanism to impart robustness with respect to morphogen dosage can 239 control the width, shape, and amplitude of the Dl gradient. Our previous work has shown that facilitated 240 diffusion, also known as shuttling, combined with saturation of the active Toll receptor, can produce the 241 wider, flatter gradients observed in the 1x embryos [26] . Given the saturation of the active Toll receptor, 242 this same mechanism may allow for negligibly taller Dl gradients in 4x embryos. Furthermore, we have 243 seen that 1x embryos that also have compromised shuttling are non-viable [26] . Therefore, to test 244 whether such a combination of mechanisms -shuttling and Toll saturation, together with deconvolution 245 (Fig. 2C) The model of Dl/Cact interactions analyzed here is based on previous models of the Dl gradient 250 [22, 24, 26, 30] . In particular, we assume that Dl, Cact, and Dl/Cact complex can bind, diffuse, and enter and 251 exit the nucleus; and that Toll signaling can be modeled using a Michaelis-Menten-like formulation (see 252
Methods and Eqns 2-4) [26] . Using this model, we performed a random parameter search to screen for 253 parameter sets in which the Dl nuclear gradient was robust to changes in maternal dl dosage (Fig. 5 A-G,  254 see Methods for more details). 255
We found three trends in the parameter sets necessary for robustness. First, all robust parameter sets 256 predicted that the free Dl nuclear intensity drops to near zero on the dorsal side of the embryo, a result 257 consistent with the deconvolution hypothesis that suggests that Dl fluorescence, as observed in 258 immunostaining experiments or in live embryos expressing Dl-GFP, represents both free Dl and Dl/Cact 259 complex, and that it is important to distinguish between the two [22] . This observation may be similar to 260 the result seen in Fig. 2C , in which decay of the Dl gradient to zero at the dorsal midline improved 261 robustness. Fig. 5A shows the concentration gradient of free Dl for all three values of dosage (1x, 2x, 4x) 262 for one of the robust parameter sets; it can be seen that all concentration curves fall to zero around lateral 263 regions of the embryo. These same parameter sets predict a gradient of Dl/Cact complex that is non-zero 264 at the dorsal midline (S1 Fig), suggesting that, in these simulated embryos, direct fluorescence 265 measurements (the sum of Dl and Dl/Cact in the nucleus) would reveal what appears to be a non-robust 266 13 Dl gradient. Furthermore, the model does not universally predict that the Dl gradient decays to zero at 267 the dorsal midline. While all robust parameter sets do so, many rejected parameter sets do not (S2 Fig). 268 Thus, the model results strongly suggest deconvolution is necessary for robustness. 269
Second, we found that the effective diffusivity of Dl/Cact complex is greater than that of free Dl in nearly 270 all robust parameter sets. As the flux of Dl/Cact complex is ventrally directed (i.e., shuttling), this result 271 implies that there is a net flux of Dl from dorsal to ventral regions [26] . We plotted the distribution of the 272 ratio of the effective diffusivity of Dl/Cact complex to that of free Dl, henceforth called ratio of length 273 scales (ρ), in Fig. 5B . In over 95% of the robust parameter sets, this ratio was found to be greater than 274 one. Thus, the constraint of robust gene expression rejects most parameter sets that do not entail 275 facilitated diffusion of Dl by Cact. 276 Finally, the model also suggests that saturation of Toll receptors is necessary for robustness of gene 277 expression. In all robust parameter sets, the saturation constant for Toll signaling, , was between 0.001 278 and 2. Indeed, as seen in Fig.5C , was the most tightly constrained parameter, which implies tight 279 regulation of Toll saturation may be the most important aspect of the mechanism to ensure robustness 280 of gene expression. This shows that the constraints in the model overwhelmingly favor saturation of Toll 281 receptors by the Dl/Cact complex, as the concentration of Dl/Cact complex in our equations has been 282 scaled to be of order 1. Taken together, these modeling results suggest that the mechanisms of 283 deconvolution and Toll saturation are necessary for a robust DV system, while shuttling of Dl by Cact 284 greatly improves the chances of robustness [22, 26] . 285 286
Model predictions of amplitude ratios 287
In addition to endorsement of the above three mechanisms, the model makes a specific prediction 288 regarding the ratios of amplitudes of the 1x and 4x embryos to that of the wildtype (2x). As seen in Fig. 5  289   14 D,E the ratio of amplitudes of 1x embryos:2x embryos is overwhelmingly favored to be greater than 0.5 290 but less than 0.9, and that of 4x embryos:2x embryos is favored to fall between 1 and 1.55. 291
It can be seen from Fig. 5 D,E that as the value of decreases (and thus, Toll becomes more saturated), 292 the range of amplitude ratios available to robust descriptions of the Dl gradient increases. For lower values 293 of , a range of 1.1 to 1.6 is accepted by the model for ratio of amplitudes of 4x embryos:2x embryos and 294 a range of 0.5 to 0.85 for ratio of amplitudes of 1x embryos:2x embryos. At higher values of κ, the values 295 of the amplitude ratios for 4x/2x and 1x/2x seem to converge to 1.45 and 0.57 respectively, meaning that 296 as Toll is more easily saturated (lower values of ), the model allows for a small, but noticeable range of 297 amplitude ratios for varying dosages. This result seems to indicate that under constrained conditions of 298 Toll saturation, only particular peak amplitudes are preferred -about 1.55 times the wildtype value for 299 4x embryos and about 0.57 times the wildtype value for 1x embryos. However, if Toll receptors saturate 300 easily, an appreciable range of amplitude ratios leads to robustness. Thus, Toll saturation seems to be an 301 inherent mechanism for robustness in the embryo. 302
In a similar way, the model predicts that the extent of shuttling of Dl by Cact also affects the acceptable 303 values of the amplitude ratios. In Fig. 5 F,G we plotted amplitude ratios against ratio of length scales, and 304 we see that when facilitated diffusion by Cact does not occur (about 5% of parameter sets), the amplitude 305 ratios of 4x/2x and 1x/2x are constrained around 1.45 and 0.57, respectively. The values of amplitudes 306 seem to converge to similar values when Toll saturation was minimal. On the other hand, when the length 307 scale ratio is greater than 1, a wider range of amplitude ratios are accessible to the embryo. 308
Thus, it seems that both Toll saturation and shuttling of Dl from dorsal to ventral regions allows the 309 embryos to explore a wider range of amplitude ratios, which allows greater flexibility for robustness. 310
However, when the above mechanisms are constrained, the amplitude ratios must take on specific values, 311 which in turn makes it difficult to achieve robustness. 312 15 313
Discussion 314
Animal development is a complex process that must be buffered against myriad environmental, 315 nutritional, and genetic perturbations. The robustness of development with respect to these 316 perturbations often requires regulatory mechanisms. Here we investigated the robustness of gene 317 expression in the early Drosophila embryo with respect to variations in the maternal gene dosage of the 318 NF-κB transcription factor Dorsal in a quantitative and computational manner. The NF-κB pathway is 319 highly conserved and is centrally involved in a diverse array of cellular processes, including inflammation, 320 apoptosis, and innate immunity. In flies, Dl/NF-κB also directs embryonic development and 321 differentiation. However, essential questions related to NF-κB robustness in Drosophila remain 322
unresolved. Our analysis of an empirical, dosage-scaling description of the Dl gradient, together with 323 detailed measurements of the Dl gradient and its target genes, suggest that a mechanism to control the 324 shape, width, and amplitude of the Dl gradient is necessary for robustness. Our previous work found three 325 novel mechanisms in the establishment of the Dl gradient: deconvolution, shuttling, and Toll saturation 326 [22, 26] . In this paper, we used a computational model to study the importance of each of these 327 mechanisms for the robustness of the Dl system. 328
Recent work showed the importance of deconvolving experimentally-measured fluorescence signal into 329 free Dl and bound Dl (Dl/Cact complex) when interpreting the Dl gradient [22] . Doing so results in a nuclear 330
Dl gradient that drops to near zero instead of to non-zero basal levels at dorsal regions [5, 15, 20, 21] . In 331 the dosage-scaling model, deconvolution was modeled by setting basal levels to near zero. While this 332 choice of basal levels improved robustness somewhat in the dosage-scaling model, the gene expression 333 boundaries remained overly sensitive to dl dosage. Furthermore, every robust parameter set in the 334 computational model predicted a free Dl gradient that decayed to near zero, whereas non-robust 335 16 parameter sets did not. Thus, while deconvolution by itself is not sufficient to explain the robustness of 336 gene expression boundaries, it appears to be a necessary piece. 337
Our model also suggests the shuttling mechanism increases robustness of the Dl system. In such a 338 mechanism, Toll signaling creates a sink for Dl/Cact complex, which establishes a ventrally-directed flux 339 to accumulate Dl in ventral regions. While it is possible that free Dl then diffuses dorsally, such counter-340 diffusion is likely mitigated by capture of free Dl by the nuclei. Previous work in our lab suggests that 341 shuttling of Dl/Cact complex from dorsal to ventral regions is an important factor for robustness in the 342 embryo [26] . Our model supports this result, as most parameter sets that selected for robust gene 343 expression favored facilitated diffusion of Dl by Cact, as the effective diffusivity of Dl/Cact was higher than 344 that of free Dl. 345
Previous work also suggested that, in wildtype embryos, active Toll receptors are limiting [26], thereby 346 maintaining robust gene expression, even when dl dosage varies from wildtype. In wildtype embryos, 347 when active Toll signaling complexes are saturated with Dl/Cact complex, a significant number of Dl/Cact 348 complexes bypass the ventral-lateral regions without being dissociated, and Dl is shuttled to the ventral-349 most portions of the embryo. On the other hand, if active Toll signaling complexes are not saturated, as 350 may be the case in 1x embryos, the Dl/Cact complex will be dissociated at a higher rate in the ventral-351 lateral regions of the embryo and will be unable to reach the ventral-most regions of the embryo. The lack 352 of Toll saturation in 1x embryos thus results in a flatter and wider concentration gradient of nuclear Dl. 353
While embryos with 4 copies of dl have double the wildtype Dl dose, twice as much Dl will not necessarily 354 enter the nuclei because that process relies on Toll signaling, which may be saturated. Similarly, 355 decreasing the dl dosage, as in the case of 1x embryos, implies halving the amount of Dl/Cact complex 356 without reducing the absolute number of free Dl molecules that will enter the nuclei. If the active Toll 357 complexes remain constant in all three cases of dosage and provided that they are saturated, only minor 358 variations occur in the concentration of free Dl when dosage changes ( Fig 5A) . 359
In this work we have demonstrated the importance of certain built-in mechanisms within the early 360 All embryos were aged to NC 14 (approx. 2-4 hours after egg lay), then fixed in 37% formaldehyde 374 according to standard protocols [34] . A combination fluorescent in situ hybridization/fluorescent 375 immnuostaining was performed according to standard protocols [34] . Briefly, fixed embryos were washed 376 in PBS/Tween and hybridized at 55 o C overnight with anti-sense RNA probes, which were generated 377 according to standard lab protocol. The embryos were then washed and incubated with primary 378 antibodies at 4 o C overnight. The next day, they were washed and incubated for 1-2 hrs with fluorescent 379 18 secondary antibodies at room temperature. The embryos were then washed and stored in 70% glycerol 380 at -20 o C. Embryos were imaged within one month of completing the protocol. 381
Antibodies used were anti-dorsal 7A4 (deposited to the DSHB by Ruth Steward (DSHB Hybridoma Product 382 anti-dorsal 7A4)) (1:10), donkey anti-mouse-488 (Invitrogen A21202, Lot 81493) (1:500), rabbit anti-383 histone (abcam ab1791, Lot 940487) (1:5000), donkey anti-rabbit-546 (Invitrogen A10040, Lot 107388) 384
(1:500), goat anti-biotin (ImmunoReagents, Raleigh, NC, GtxOt-070-D, Lot 19-19-112311 Images of embryo cross sections were analyzed using a previously derived algorithm [36] . Briefly, the 400 border of the embryo was found computationally, then the nuclei were segmented using a local 401 19 thresholding protocol. The intensity of dl in each segmented nucleus was calculated as the ratio between 402 the intensity in the dl channel divided by the intensity in the nuclear channel. The intensity of mRNA 403 expression was calculated as average intensity within an annulus roughly 18 μm wide around the 404 perimeter of the embryo. mRNA profiles were fit to canonical parameters; those with a goodness of fit 405 (gof) less than 0.7 were omitted from study. 406
All dl gradients were fit to a Gaussian, and these fits were used to determine the width parameter, σ. 407
Gradients with a gof less than 0.8 were eliminated from the results. Normalized intensity plots were 408 generated by fitting each embryo's data to its own Gaussian by subtracting the B value and 70% of the M 409 value, then dividing by the A value. (X = (x -B -0.7M)/A)). The average normalized intensity plot was 410 generated by averaging the plots of all embryos in the specified genotype. 411
Multiple experiments with statistically similar wild type controls were analyzed simultaneously to 412 generate the data in this report. Statistical significance was calculated using two-tailed homoscedastic t-413 tests. 414
415

Model equations 416
The equations for the computational model are as follows: 417 
where ̃/ = / 14 (see Supplementary information for details). 438
The simulation was run for 60 min, which approximates the time period of NC 14, which is the longest 439 nuclear cycle of the blastoderm. Dosage was varied by doubling or halving the initial concentration of 440 Dl/Cact. The ldimensionless constants obtained from it were then varied from 1e-3 to 1e+3 to obtain 441 21 concentration profiles for Dl and Dl/Cact. From these concentration profiles, the dorsal border of sna and 442 the ventral and dorsal borders of sog were calculated assuming the borders are defined by thresholds of 443 free Dl concentration. These model predictions of the borders were compared with experimental values 444 in the least square error sense and parameter sets with errors lower than a set value were accepted as 445 robust (see Supplementary information for details). 
